Giancarlo Glick

All Publications

• A Multi-Site Evaluation of a Psychedelic Medicine Curriculum for Psychiatry Trainees. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry Yaden, M. E., O'Donnell, K. C., Roberts, D. E., Goldway, N., Tiwari, P., Ching, T. H., Hokanson, J., Gukasyan, N., Appold, B., Glick, G., Kelmendi, B., Ross, S., Pittenger, C. 2026

  Abstract

  Interest in psychedelic medicine is increasing, yet psychiatry trainees report limited education in this area. The authors developed a standardized curriculum and evaluated its impact on trainee knowledge and attitudes toward psychedelic medicines.A 6-h psychedelic medicine course was delivered across four psychiatry residency programs in the Northeast United States in 2025-2026. The curriculum included six modules covering foundational concepts and evidence, as well as clinical considerations. Anonymous pre- and post-course surveys assessed knowledge, interest, and confidence in counseling. Statistical comparisons were used to evaluate pre-post changes.Forty trainees participated across institutions; 34 completed a pre-course survey and 22 completed a post-course survey. Most trainees reported minimal prior didactic exposure to psychedelic medicine. Self-assessed knowledge as well as scores on a knowledge quiz improved significantly following the course. Self-rated understanding of both the rationale for psychedelic treatments and limitations of evidence increased. Most substantially, confidence in counseling patients about clinical research, harm reduction, and treatment risks improved across domains. Baseline interest in psychedelic medicine was high at the start of the course and did not change significantly following its completion.A multi-site curriculum in psychedelic medicine was associated with increased knowledge and counseling confidence in trainees. The curriculum did not significantly impact interest or plans to pursue opportunities in psychedelic medicine, suggesting the course did not overinflate enthusiasm for the field. Standardized curricula in residency education may help address gaps in psychiatric training as clinicians increasingly encounter questions about these emerging treatments.

  View details for DOI 10.1007/s40596-026-02444-3

  View details for PubMedID 42778871

  View details for PubMedCentralID 11370688

• What Is in a Name? The Many Meanings of “Psychedelic” Psychedelic Medicine O'Donnell, K., Glick, G., et al 2023

  View details for DOI 10.1089/psymed.2023.0011

• Psychedelic-Assisted Group Therapy: A Systematic Review JOURNAL OF PSYCHOACTIVE DRUGS Trope, A., Anderson, B. T., Hooker, A. R., Glick, G., Stauffer, C., Woolley, J. D. 2019; 51 (2): 174-188

  Abstract

  Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation. Several recent reviews that highlight the contributions of this early literature have focused on psychedelic-assisted individual psychotherapy modalities. None have attempted to systematically identify and compile experimental studies of psychedelic-assisted group therapy. In therapeutic settings, psychedelics were often used to enhance group therapy for a variety of populations and clinical indications. We report on the results of a systematic review of the published literature in English and Spanish on psychedelic-assisted group therapies. Publications are characterized by their clinical approach, experimental method, and clinical outcomes. Given the renewed interest in the clinical use of psychedelic medicines, this review aims to stimulate hypotheses to be tested in future research on psychedelic-assisted psychotherapy, group process, and interpersonal functioning.

  View details for DOI 10.1080/02791072.2019.1593559

  View details for Web of Science ID 000465678000001

  View details for PubMedID 30950777

  View details for PubMedCentralID PMC6650145